267 related articles for article (PubMed ID: 18192745)
1. Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
Adler NE; Koschorreck J; Rechenberg B
Water Sci Technol; 2008; 57(1):91-7. PubMed ID: 18192745
[TBL] [Abstract][Full Text] [Related]
2. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
3. Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals.
Küster A; Bachmann J; Brandt U; Ebert I; Hickmann S; Klein-Goedicke J; Maack G; Schmitz S; Thumm E; Rechenberg B
Regul Toxicol Pharmacol; 2009 Dec; 55(3):276-80. PubMed ID: 19607869
[TBL] [Abstract][Full Text] [Related]
4. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
[TBL] [Abstract][Full Text] [Related]
5. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
Laenge R; Steger-Hartmann T; Schweinfurth H
Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
[TBL] [Abstract][Full Text] [Related]
6. The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges.
Kümmerer K
J Environ Manage; 2009 Jun; 90(8):2354-66. PubMed ID: 19261375
[TBL] [Abstract][Full Text] [Related]
7. [Study on environmental risk assessment of drugs: excretion forms to environment].
Hirata-Koizumi M; Saito M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006; (124):83-6. PubMed ID: 17405530
[TBL] [Abstract][Full Text] [Related]
8. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
9. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP; Garric J
Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
[TBL] [Abstract][Full Text] [Related]
10. Leaching behaviour of pharmaceuticals in soil-testing-systems: a part of an environmental risk assessment for groundwater protection.
Oppel J; Broll G; Löffler D; Meller M; Römbke J; Ternes T
Sci Total Environ; 2004 Jul; 328(1-3):265-73. PubMed ID: 15207589
[TBL] [Abstract][Full Text] [Related]
11. Environmental risk assessment of medicinal products for human use according to European Commission recommendations.
Huschek G; Hansen PD; Maurer HH; Krengel D; Kayser A;
Environ Toxicol; 2004 Jun; 19(3):226-40. PubMed ID: 15101038
[TBL] [Abstract][Full Text] [Related]
12. Development of a common priority list of pharmaceuticals relevant for the water cycle.
de Voogt P; Janex-Habibi ML; Sacher F; Puijker L; Mons M
Water Sci Technol; 2009; 59(1):39-46. PubMed ID: 19151484
[TBL] [Abstract][Full Text] [Related]
13. Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.
Ågerstrand M; Küster A; Bachmann J; Breitholtz M; Ebert I; Rechenberg B; Rudén C
Environ Pollut; 2011 Oct; 159(10):2487-92. PubMed ID: 21763042
[TBL] [Abstract][Full Text] [Related]
14. A ranking of European veterinary medicines based on environmental risks.
Kools SA; Boxall A; Moltmann JF; Bryning G; Koschorreck J; Knacker T
Integr Environ Assess Manag; 2008 Oct; 4(4):399-408. PubMed ID: 18563959
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment.
Brooks BW; Berninger JP; Kristofco LA; Ramirez AJ; Stanley JK; Valenti TW
Prog Mol Biol Transl Sci; 2012; 112():231-58. PubMed ID: 22974742
[TBL] [Abstract][Full Text] [Related]
16. [Health impact assessment of building and investment projects].
Thriene B
Gesundheitswesen; 2003 Feb; 65(2):118-24. PubMed ID: 12632322
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals in the environment: scientific evidence of risks and its regulation.
Küster A; Adler N
Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405974
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals in the environment--a human risk?
Christensen FM
Regul Toxicol Pharmacol; 1998 Dec; 28(3):212-21. PubMed ID: 10049792
[TBL] [Abstract][Full Text] [Related]
19. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
Wajsman D; Rudén C
J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
[TBL] [Abstract][Full Text] [Related]
20. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL; Binks SP; Olson MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
